▶ 調査レポート

世界のβ-サラセミア検査市場 2021:企業別、地域別、種類・用途別

• 英文タイトル:Global Beta Thalassemia Testing Market 2021 by Company, Regions, Type and Application, Forecast to 2026

GlobalInfoResearchが調査・発行した産業分析レポートです。世界のβ-サラセミア検査市場 2021:企業別、地域別、種類・用途別 / Global Beta Thalassemia Testing Market 2021 by Company, Regions, Type and Application, Forecast to 2026 / GIR-107A12086資料のイメージです。• レポートコード:GIR-107A12086
• 出版社/出版日:GlobalInfoResearch / 2021年7月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、82ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料では、β-サラセミア検査のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。β-サラセミア検査の種類別市場規模(キット、消耗品)、用途別市場規模(病院・専門クリニック、診断センター、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・β-サラセミア検査の市場概要
・企業情報(企業概要、製品概要、販売量、価格、売上):MedGenome、3B BlackBio Biotech India Limited、Bio-Rad Laboratories, Inc.、ViennaLab Diagnostics、Thermo Fisher Scientific Inc.、PerkinElmer Inc.、BioMedomics, Inc.、Asper Biogene、Tosoh Bioscience, Inc.
・企業別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:キット、消耗品
・用途別分析2016年-2026年:病院・専門クリニック、診断センター、その他
・β-サラセミア検査の北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・β-サラセミア検査のヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・β-サラセミア検査のアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・β-サラセミア検査の南米市場規模2016年-2026年:ブラジル、アルゼンチン
・β-サラセミア検査の中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Beta Thalassemia Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Beta Thalassemia Testing size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Beta Thalassemia Testing market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Beta Thalassemia Testing market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Kits
Consumables

Market segment by Application, can be divided into
Hospitals and Specialty Clinics
Diagnostics Centers
Others

Market segment by players, this report covers
MedGenome
3B BlackBio Biotech India Limited
Bio-Rad Laboratories, Inc.
ViennaLab Diagnostics
Thermo Fisher Scientific Inc.
PerkinElmer Inc.
BioMedomics, Inc.
Asper Biogene
Tosoh Bioscience, Inc.

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Beta Thalassemia Testing product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Beta Thalassemia Testing, with revenue, gross margin and global market share of Beta Thalassemia Testing from 2019 to 2021.
Chapter 3, the Beta Thalassemia Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Beta Thalassemia Testing market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Beta Thalassemia Testing research findings and conclusion, appendix and data source.

レポート目次

1 Market Overview
1.1 Product Overview and Scope of Beta Thalassemia Testing
1.2 Classification of Beta Thalassemia Testing by Type
1.2.1 Overview: Global Beta Thalassemia Testing Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Beta Thalassemia Testing Revenue Market Share by Type in 2020
1.2.3 Kits
1.2.4 Consumables
1.3 Global Beta Thalassemia Testing Market by Application
1.3.1 Overview: Global Beta Thalassemia Testing Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals and Specialty Clinics
1.3.3 Diagnostics Centers
1.3.4 Others
1.4 Global Beta Thalassemia Testing Market Size & Forecast
1.5 Global Beta Thalassemia Testing Market Size and Forecast by Region
1.5.1 Global Beta Thalassemia Testing Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Beta Thalassemia Testing Market Size by Region, (2016-2021)
1.5.3 North America Beta Thalassemia Testing Market Size and Prospect (2016-2026)
1.5.4 Europe Beta Thalassemia Testing Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Beta Thalassemia Testing Market Size and Prospect (2016-2026)
1.5.6 South America Beta Thalassemia Testing Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Beta Thalassemia Testing Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Beta Thalassemia Testing Market Drivers
1.6.2 Beta Thalassemia Testing Market Restraints
1.6.3 Beta Thalassemia Testing Trends Analysis
2 Company Profiles
2.1 MedGenome
2.1.1 MedGenome Details
2.1.2 MedGenome Major Business
2.1.3 MedGenome Beta Thalassemia Testing Product and Solutions
2.1.4 MedGenome Beta Thalassemia Testing Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 MedGenome Recent Developments and Future Plans
2.2 3B BlackBio Biotech India Limited
2.2.1 3B BlackBio Biotech India Limited Details
2.2.2 3B BlackBio Biotech India Limited Major Business
2.2.3 3B BlackBio Biotech India Limited Beta Thalassemia Testing Product and Solutions
2.2.4 3B BlackBio Biotech India Limited Beta Thalassemia Testing Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 3B BlackBio Biotech India Limited Recent Developments and Future Plans
2.3 Bio-Rad Laboratories, Inc.
2.3.1 Bio-Rad Laboratories, Inc. Details
2.3.2 Bio-Rad Laboratories, Inc. Major Business
2.3.3 Bio-Rad Laboratories, Inc. Beta Thalassemia Testing Product and Solutions
2.3.4 Bio-Rad Laboratories, Inc. Beta Thalassemia Testing Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Bio-Rad Laboratories, Inc. Recent Developments and Future Plans
2.4 ViennaLab Diagnostics
2.4.1 ViennaLab Diagnostics Details
2.4.2 ViennaLab Diagnostics Major Business
2.4.3 ViennaLab Diagnostics Beta Thalassemia Testing Product and Solutions
2.4.4 ViennaLab Diagnostics Beta Thalassemia Testing Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 ViennaLab Diagnostics Recent Developments and Future Plans
2.5 Thermo Fisher Scientific Inc.
2.5.1 Thermo Fisher Scientific Inc. Details
2.5.2 Thermo Fisher Scientific Inc. Major Business
2.5.3 Thermo Fisher Scientific Inc. Beta Thalassemia Testing Product and Solutions
2.5.4 Thermo Fisher Scientific Inc. Beta Thalassemia Testing Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Thermo Fisher Scientific Inc. Recent Developments and Future Plans
2.6 PerkinElmer Inc.
2.6.1 PerkinElmer Inc. Details
2.6.2 PerkinElmer Inc. Major Business
2.6.3 PerkinElmer Inc. Beta Thalassemia Testing Product and Solutions
2.6.4 PerkinElmer Inc. Beta Thalassemia Testing Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 PerkinElmer Inc. Recent Developments and Future Plans
2.7 BioMedomics, Inc.
2.7.1 BioMedomics, Inc. Details
2.7.2 BioMedomics, Inc. Major Business
2.7.3 BioMedomics, Inc. Beta Thalassemia Testing Product and Solutions
2.7.4 BioMedomics, Inc. Beta Thalassemia Testing Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 BioMedomics, Inc. Recent Developments and Future Plans
2.8 Asper Biogene
2.8.1 Asper Biogene Details
2.8.2 Asper Biogene Major Business
2.8.3 Asper Biogene Beta Thalassemia Testing Product and Solutions
2.8.4 Asper Biogene Beta Thalassemia Testing Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Asper Biogene Recent Developments and Future Plans
2.9 Tosoh Bioscience, Inc.
2.9.1 Tosoh Bioscience, Inc. Details
2.9.2 Tosoh Bioscience, Inc. Major Business
2.9.3 Tosoh Bioscience, Inc. Beta Thalassemia Testing Product and Solutions
2.9.4 Tosoh Bioscience, Inc. Beta Thalassemia Testing Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Tosoh Bioscience, Inc. Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Beta Thalassemia Testing Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Beta Thalassemia Testing Players Market Share
3.2.2 Top 10 Beta Thalassemia Testing Players Market Share
3.2.3 Market Competition Trend
3.3 Beta Thalassemia Testing Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Beta Thalassemia Testing Revenue and Market Share by Type (2016-2021)
4.2 Global Beta Thalassemia Testing Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Beta Thalassemia Testing Revenue Market Share by Application (2016-2021)
5.2 Beta Thalassemia Testing Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Beta Thalassemia Testing Revenue by Type (2016-2026)
6.2 North America Beta Thalassemia Testing Revenue by Application (2016-2026)
6.3 North America Beta Thalassemia Testing Market Size by Country
6.3.1 North America Beta Thalassemia Testing Revenue by Country (2016-2026)
6.3.2 United States Beta Thalassemia Testing Market Size and Forecast (2016-2026)
6.3.3 Canada Beta Thalassemia Testing Market Size and Forecast (2016-2026)
6.3.4 Mexico Beta Thalassemia Testing Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Beta Thalassemia Testing Revenue by Type (2016-2026)
7.2 Europe Beta Thalassemia Testing Revenue by Application (2016-2026)
7.3 Europe Beta Thalassemia Testing Market Size by Country
7.3.1 Europe Beta Thalassemia Testing Revenue by Country (2016-2026)
7.3.2 Germany Beta Thalassemia Testing Market Size and Forecast (2016-2026)
7.3.3 France Beta Thalassemia Testing Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Beta Thalassemia Testing Market Size and Forecast (2016-2026)
7.3.5 Russia Beta Thalassemia Testing Market Size and Forecast (2016-2026)
7.3.6 Italy Beta Thalassemia Testing Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Beta Thalassemia Testing Revenue by Type (2016-2026)
8.2 Asia-Pacific Beta Thalassemia Testing Revenue by Application (2016-2026)
8.3 Asia-Pacific Beta Thalassemia Testing Market Size by Region
8.3.1 Asia-Pacific Beta Thalassemia Testing Revenue by Region (2016-2026)
8.3.2 China Beta Thalassemia Testing Market Size and Forecast (2016-2026)
8.3.3 Japan Beta Thalassemia Testing Market Size and Forecast (2016-2026)
8.3.4 South Korea Beta Thalassemia Testing Market Size and Forecast (2016-2026)
8.3.5 India Beta Thalassemia Testing Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Beta Thalassemia Testing Market Size and Forecast (2016-2026)
8.3.7 Australia Beta Thalassemia Testing Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Beta Thalassemia Testing Revenue by Type (2016-2026)
9.2 South America Beta Thalassemia Testing Revenue by Application (2016-2026)
9.3 South America Beta Thalassemia Testing Market Size by Country
9.3.1 South America Beta Thalassemia Testing Revenue by Country (2016-2026)
9.3.2 Brazil Beta Thalassemia Testing Market Size and Forecast (2016-2026)
9.3.3 Argentina Beta Thalassemia Testing Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Beta Thalassemia Testing Revenue by Type (2016-2026)
10.2 Middle East & Africa Beta Thalassemia Testing Revenue by Application (2016-2026)
10.3 Middle East & Africa Beta Thalassemia Testing Market Size by Country
10.3.1 Middle East & Africa Beta Thalassemia Testing Revenue by Country (2016-2026)
10.3.2 Turkey Beta Thalassemia Testing Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Beta Thalassemia Testing Market Size and Forecast (2016-2026)
10.3.4 UAE Beta Thalassemia Testing Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Beta Thalassemia Testing Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Beta Thalassemia Testing Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Beta Thalassemia Testing Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Beta Thalassemia Testing Revenue (USD Million) by Region (2016-2021)
Table 5. Global Beta Thalassemia Testing Revenue Market Share by Region (2021-2026)
Table 6. MedGenome Corporate Information, Head Office, and Major Competitors
Table 7. MedGenome Major Business
Table 8. MedGenome Beta Thalassemia Testing Product and Solutions
Table 9. MedGenome Beta Thalassemia Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. 3B BlackBio Biotech India Limited Corporate Information, Head Office, and Major Competitors
Table 11. 3B BlackBio Biotech India Limited Major Business
Table 12. 3B BlackBio Biotech India Limited Beta Thalassemia Testing Product and Solutions
Table 13. 3B BlackBio Biotech India Limited Beta Thalassemia Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Bio-Rad Laboratories, Inc. Corporate Information, Head Office, and Major Competitors
Table 15. Bio-Rad Laboratories, Inc. Major Business
Table 16. Bio-Rad Laboratories, Inc. Beta Thalassemia Testing Product and Solutions
Table 17. Bio-Rad Laboratories, Inc. Beta Thalassemia Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. ViennaLab Diagnostics Corporate Information, Head Office, and Major Competitors
Table 19. ViennaLab Diagnostics Major Business
Table 20. ViennaLab Diagnostics Beta Thalassemia Testing Product and Solutions
Table 21. ViennaLab Diagnostics Beta Thalassemia Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Thermo Fisher Scientific Inc. Corporate Information, Head Office, and Major Competitors
Table 23. Thermo Fisher Scientific Inc. Major Business
Table 24. Thermo Fisher Scientific Inc. Beta Thalassemia Testing Product and Solutions
Table 25. Thermo Fisher Scientific Inc. Beta Thalassemia Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. PerkinElmer Inc. Corporate Information, Head Office, and Major Competitors
Table 27. PerkinElmer Inc. Major Business
Table 28. PerkinElmer Inc. Beta Thalassemia Testing Product and Solutions
Table 29. PerkinElmer Inc. Beta Thalassemia Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. BioMedomics, Inc. Corporate Information, Head Office, and Major Competitors
Table 31. BioMedomics, Inc. Major Business
Table 32. BioMedomics, Inc. Beta Thalassemia Testing Product and Solutions
Table 33. BioMedomics, Inc. Beta Thalassemia Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Asper Biogene Corporate Information, Head Office, and Major Competitors
Table 35. Asper Biogene Major Business
Table 36. Asper Biogene Beta Thalassemia Testing Product and Solutions
Table 37. Asper Biogene Beta Thalassemia Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Tosoh Bioscience, Inc. Corporate Information, Head Office, and Major Competitors
Table 39. Tosoh Bioscience, Inc. Major Business
Table 40. Tosoh Bioscience, Inc. Beta Thalassemia Testing Product and Solutions
Table 41. Tosoh Bioscience, Inc. Beta Thalassemia Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Global Beta Thalassemia Testing Revenue (USD Million) by Players (2019-2021)
Table 43. Global Beta Thalassemia Testing Revenue Share by Players (2019-2021)
Table 44. Breakdown of Beta Thalassemia Testing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 45. Beta Thalassemia Testing Players Head Office, Products and Services Provided
Table 46. Beta Thalassemia Testing Mergers & Acquisitions in the Past Five Years
Table 47. Beta Thalassemia Testing New Entrants and Expansion Plans
Table 48. Global Beta Thalassemia Testing Revenue (USD Million) by Type (2016-2021)
Table 49. Global Beta Thalassemia Testing Revenue Share by Type (2016-2021)
Table 50. Global Beta Thalassemia Testing Revenue Forecast by Type (2021-2026)
Table 51. Global Beta Thalassemia Testing Revenue by Application (2016-2021)
Table 52. Global Beta Thalassemia Testing Revenue Forecast by Application (2021-2026)
Table 53. North America Beta Thalassemia Testing Revenue by Type (2016-2021) & (USD Million)
Table 54. North America Beta Thalassemia Testing Revenue by Type (2021-2026) & (USD Million)
Table 55. North America Beta Thalassemia Testing Revenue by Application (2016-2021) & (USD Million)
Table 56. North America Beta Thalassemia Testing Revenue by Application (2021-2026) & (USD Million)
Table 57. North America Beta Thalassemia Testing Revenue by Country (2016-2021) & (USD Million)
Table 58. North America Beta Thalassemia Testing Revenue by Country (2021-2026) & (USD Million)
Table 59. Europe Beta Thalassemia Testing Revenue by Type (2016-2021) & (USD Million)
Table 60. Europe Beta Thalassemia Testing Revenue by Type (2021-2026) & (USD Million)
Table 61. Europe Beta Thalassemia Testing Revenue by Application (2016-2021) & (USD Million)
Table 62. Europe Beta Thalassemia Testing Revenue by Application (2021-2026) & (USD Million)
Table 63. Europe Beta Thalassemia Testing Revenue by Country (2016-2021) & (USD Million)
Table 64. Europe Beta Thalassemia Testing Revenue by Country (2021-2026) & (USD Million)
Table 65. Asia-Pacific Beta Thalassemia Testing Revenue by Type (2016-2021) & (USD Million)
Table 66. Asia-Pacific Beta Thalassemia Testing Revenue by Type (2021-2026) & (USD Million)
Table 67. Asia-Pacific Beta Thalassemia Testing Revenue by Application (2016-2021) & (USD Million)
Table 68. Asia-Pacific Beta Thalassemia Testing Revenue by Application (2021-2026) & (USD Million)
Table 69. Asia-Pacific Beta Thalassemia Testing Revenue by Region (2016-2021) & (USD Million)
Table 70. Asia-Pacific Beta Thalassemia Testing Revenue by Region (2021-2026) & (USD Million)
Table 71. South America Beta Thalassemia Testing Revenue by Type (2016-2021) & (USD Million)
Table 72. South America Beta Thalassemia Testing Revenue by Type (2021-2026) & (USD Million)
Table 73. South America Beta Thalassemia Testing Revenue by Application (2016-2021) & (USD Million)
Table 74. South America Beta Thalassemia Testing Revenue by Application (2021-2026) & (USD Million)
Table 75. South America Beta Thalassemia Testing Revenue by Country (2016-2021) & (USD Million)
Table 76. South America Beta Thalassemia Testing Revenue by Country (2021-2026) & (USD Million)
Table 77. Middle East & Africa Beta Thalassemia Testing Revenue by Type (2016-2021) & (USD Million)
Table 78. Middle East & Africa Beta Thalassemia Testing Revenue by Type (2021-2026) & (USD Million)
Table 79. Middle East & Africa Beta Thalassemia Testing Revenue by Application (2016-2021) & (USD Million)
Table 80. Middle East & Africa Beta Thalassemia Testing Revenue by Application (2021-2026) & (USD Million)
Table 81. Middle East & Africa Beta Thalassemia Testing Revenue by Country (2016-2021) & (USD Million)
Table 82. Middle East & Africa Beta Thalassemia Testing Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Beta Thalassemia Testing Picture
Figure 2. Global Beta Thalassemia Testing Revenue Market Share by Type in 2020
Figure 3. Kits
Figure 4. Consumables
Figure 5. Beta Thalassemia Testing Revenue Market Share by Application in 2020
Figure 6. Hospitals and Specialty Clinics Picture
Figure 7. Diagnostics Centers Picture
Figure 8. Others Picture
Figure 9. Global Beta Thalassemia Testing Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 10. Global Beta Thalassemia Testing Revenue and Forecast (2016-2026) & (USD Million)
Figure 11. Global Beta Thalassemia Testing Revenue Market Share by Region (2016-2026)
Figure 12. Global Beta Thalassemia Testing Revenue Market Share by Region in 2020
Figure 13. North America Beta Thalassemia Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Europe Beta Thalassemia Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Asia-Pacific Beta Thalassemia Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. South America Beta Thalassemia Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Middle East and Africa Beta Thalassemia Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Beta Thalassemia Testing Market Drivers
Figure 19. Beta Thalassemia Testing Market Restraints
Figure 20. Beta Thalassemia Testing Market Trends
Figure 21. MedGenome Recent Developments and Future Plans
Figure 22. 3B BlackBio Biotech India Limited Recent Developments and Future Plans
Figure 23. Bio-Rad Laboratories, Inc. Recent Developments and Future Plans
Figure 24. ViennaLab Diagnostics Recent Developments and Future Plans
Figure 25. Thermo Fisher Scientific Inc. Recent Developments and Future Plans
Figure 26. PerkinElmer Inc. Recent Developments and Future Plans
Figure 27. BioMedomics, Inc. Recent Developments and Future Plans
Figure 28. Asper Biogene Recent Developments and Future Plans
Figure 29. Tosoh Bioscience, Inc. Recent Developments and Future Plans
Figure 30. Global Beta Thalassemia Testing Revenue Share by Players in 2020
Figure 31. Beta Thalassemia Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 32. Global Top 3 Players Beta Thalassemia Testing Revenue Market Share in 2020
Figure 33. Global Top 10 Players Beta Thalassemia Testing Revenue Market Share in 2020
Figure 34. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 35. Global Beta Thalassemia Testing Revenue Share by Type in 2020
Figure 36. Global Beta Thalassemia Testing Market Share Forecast by Type (2021-2026)
Figure 37. Global Beta Thalassemia Testing Revenue Share by Application in 2020
Figure 38. Global Beta Thalassemia Testing Market Share Forecast by Application (2021-2026)
Figure 39. North America Beta Thalassemia Testing Sales Market Share by Type (2016-2026)
Figure 40. North America Beta Thalassemia Testing Sales Market Share by Application (2016-2026)
Figure 41. North America Beta Thalassemia Testing Revenue Market Share by Country (2016-2026)
Figure 42. United States Beta Thalassemia Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Canada Beta Thalassemia Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Mexico Beta Thalassemia Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Europe Beta Thalassemia Testing Sales Market Share by Type (2016-2026)
Figure 46. Europe Beta Thalassemia Testing Sales Market Share by Application (2016-2026)
Figure 47. Europe Beta Thalassemia Testing Revenue Market Share by Country (2016-2026)
Figure 48. Germany Beta Thalassemia Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. France Beta Thalassemia Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. United Kingdom Beta Thalassemia Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Russia Beta Thalassemia Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Italy Beta Thalassemia Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Asia-Pacific Beta Thalassemia Testing Sales Market Share by Type (2016-2026)
Figure 54. Asia-Pacific Beta Thalassemia Testing Sales Market Share by Application (2016-2026)
Figure 55. Asia-Pacific Beta Thalassemia Testing Revenue Market Share by Region (2016-2026)
Figure 56. China Beta Thalassemia Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Japan Beta Thalassemia Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. South Korea Beta Thalassemia Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. India Beta Thalassemia Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Southeast Asia Beta Thalassemia Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Australia Beta Thalassemia Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South America Beta Thalassemia Testing Sales Market Share by Type (2016-2026)
Figure 63. South America Beta Thalassemia Testing Sales Market Share by Application (2016-2026)
Figure 64. South America Beta Thalassemia Testing Revenue Market Share by Country (2016-2026)
Figure 65. Brazil Beta Thalassemia Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Argentina Beta Thalassemia Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Middle East and Africa Beta Thalassemia Testing Sales Market Share by Type (2016-2026)
Figure 68. Middle East and Africa Beta Thalassemia Testing Sales Market Share by Application (2016-2026)
Figure 69. Middle East and Africa Beta Thalassemia Testing Revenue Market Share by Country (2016-2026)
Figure 70. Turkey Beta Thalassemia Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Saudi Arabia Beta Thalassemia Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. UAE Beta Thalassemia Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Methodology
Figure 74. Research Process and Data Source